Short- and Medium-Term Outcomes After Transcatheter Pulmonary Valve Placement in the Expanded Multicenter US Melody Valve Trial | Zendy

Doff B. McElhinney | Zendy; William E. Hellenbrand | Zendy; Evan M. Zahn | Zendy; Thomas K. Jones | Zendy; John P. Cheatham | Zendy; James E. Lock | Zendy; Julie A. Vincent | Zendy

Open Access

Short- and Medium-Term Outcomes After Transcatheter Pulmonary Valve Placement in the Expanded Multicenter US Melody Valve Trial

Author(s) -

Doff B. McElhinney,

William E. Hellenbrand,

Evan M. Zahn,

Thomas K. Jones,

John P. Cheatham,

James E. Lock,

Julie A. Vincent

Publication year - 2010

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.109.921692

Subject(s) - medicine , ventricular outflow tract , cardiology , pulmonary valve , regurgitation (circulation) , pulmonary artery , surgery , stent , multicenter trial , randomized controlled trial , multicenter study

Transcatheter pulmonary valve placement is an emerging therapy for pulmonary regurgitation and right ventricular outflow tract obstruction in selected patients. The Melody valve was recently approved in the United States for placement in dysfunctional right ventricular outflow tract conduits.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research